AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 176 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,385,000 | +90.2% | 157,665 | -5.7% | 1.54% | +106.3% |
Q2 2022 | $1,254,000 | -27.3% | 167,165 | -11.8% | 0.75% | -1.2% |
Q1 2022 | $1,725,000 | +28.0% | 189,565 | -1.3% | 0.76% | +38.2% |
Q4 2021 | $1,348,000 | -13.4% | 192,065 | +40.7% | 0.55% | -20.4% |
Q3 2021 | $1,556,000 | +6.4% | 136,501 | +49.5% | 0.69% | +32.6% |
Q2 2021 | $1,462,000 | -11.6% | 91,300 | -1.3% | 0.52% | -28.0% |
Q1 2021 | $1,653,000 | +249.5% | 92,500 | +164.3% | 0.72% | +268.7% |
Q4 2020 | $473,000 | -4.4% | 35,000 | +70.7% | 0.20% | -37.7% |
Q4 2019 | $495,000 | – | 20,500 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |